Current Drug Targets
Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
Contents
Current Drug Targets, Volume 6 - Number 6
Proteomics in Acute Myelogenous Leukaemia (AML): Methodological Strategies and Identification of Protein Targets for Novel Antileukaemic Therapy
, 6(6): 631 - 646G. Sjoholt, N. Anensen, L. Wergeland, E. Mc Cormack, O. Bruserud and B. T. Gjertsen
DOI: 10.2174/1389450054863671
Ribozymes, DNAzymes and Small Interfering RNAs as Therapeutics
, 6(6): 647 - 653M. Sioud and P. O. Iversen
DOI: 10.2174/1389450054863653
Protein Kinase A (PKA) - A Potential Target for Therapeutic Intervention of Dysfunctional Immune Cells
, 6(6): 655 - 664B. S. Skalhegg, A. Funderud, H. H. Henanger, T. T. Hafte, A. C. Larsen, A.- K. Kvissel, S. Eikvar and S. Orstavik
DOI: 10.2174/1389450054863644
Decreasing the Metastatic Potential in Cancers - Targeting the Heparan Sulfate Proteoglycans
, 6(6): 665 - 682K. Fjeldstad and S. O. Kolset
DOI: 10.2174/1389450054863662
Angiogenesis and Hemostasis in Hematological Neoplasias
, 6(6): 683 - 699H. Negaard, A. Dahm, P. M. Sandset, P. O. Iversen and B. Ostenstad
DOI: 10.2174/1389450054863699
Identification of New Targets for Therapy of Osteolytic Bone Disease in Multiple Myeloma
, 6(6): 701 - 711O. Hjertner, T. Standal, M. Borset, A. Sundan and A. Waage
DOI: 10.2174/1389450054863716
Editor-in-Chief
Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Advertisement
Webmaster Contact: info@benthamscience.net